George Thomas - Goodbody Health Chief Director
Insider
George Thomas is Chief Director of Goodbody Health
Web | https://www.goodbodyhealth.com |
George Thomas Latest Insider Activity
Tracking and analyzing the buying and selling activities of George Thomas against Goodbody Health otc stock is an integral part of due diligence when investing in Goodbody Health. George Thomas insider activity provides valuable insight into whether Goodbody Health is net buyers or sellers over its current business cycle. Note, Goodbody Health insiders must abide by specific rules, including filing SEC forms every time they buy or sell Goodbody Health'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
George Thomas over a year ago Purchase by George Thomas of 2000 shares of Coffee Holding |
Goodbody Health Management Efficiency
The company has return on total asset (ROA) of (0.1333) % which means that it has lost $0.1333 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.5554) %, meaning that it generated substantial loss on money invested by shareholders. Goodbody Health's management efficiency ratios could be used to measure how well Goodbody Health manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Matthias Heinzel | Merck KGaA ADR | 56 | |
Gerhard Schmitz | Merck KGaA ADR | 60 | |
Gerhard Schmitz | MERCK Kommanditgesellschaft auf | 60 | |
Matthias Heinzel | MERCK Kommanditgesellschaft auf | 56 | |
Caitlin Johnston | Avicanna | N/A | |
Ivana Maric | Avicanna | N/A | |
France Landry | Cannara Biotech | N/A | |
Mba BEcon | Avicanna | N/A | |
Dirk Toepfer | Merck KGaA ADR | N/A | |
Belen MD | MERCK Kommanditgesellschaft auf | 63 | |
Alexander Wolfe | Cannara Biotech | N/A | |
Julia Bouvet | Cannara Biotech | N/A | |
Avi Krivorot | Cannara Biotech | N/A | |
Peter Guenter | Merck KGaA ADR | 61 | |
Roland Alvarez | Avicanna | N/A | |
Barbara Weiland | MERCK Kommanditgesellschaft auf | 49 | |
Friederike Rotsch | MERCK Kommanditgesellschaft auf | 51 | |
Carlos Muete | Avicanna | N/A | |
Frantz Devedec | Avicanna | N/A | |
Belen MD | Merck KGaA ADR | 63 | |
Friederike Rotsch | Merck KGaA ADR | 51 |
Management Performance
Return On Equity | -0.56 | |||
Return On Asset | -0.13 |
Goodbody Health Leadership Team
Elected by the shareholders, the Goodbody Health's board of directors comprises two types of representatives: Goodbody Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Goodbody. The board's role is to monitor Goodbody Health's management team and ensure that shareholders' interests are well served. Goodbody Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Goodbody Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
FCCA ACIS, Company CFO | ||
Emily Critchley, Group HR | ||
George Thomas, Chief Director | ||
Krzysztof Wojtanowski, Head Poland | ||
Marc Howells, CEO Director | ||
Julia Edwards, Group Marketing | ||
Jason Dussault, Co IR |
Goodbody Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Goodbody Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.56 | |||
Return On Asset | -0.13 | |||
Profit Margin | (0.23) % | |||
Operating Margin | (0.11) % | |||
Current Valuation | (884.3 K) | |||
Shares Outstanding | 36.5 M | |||
Shares Owned By Insiders | 2.09 % | |||
Shares Owned By Institutions | 0.01 % | |||
Price To Book | 0.16 X | |||
Price To Sales | 0.15 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Goodbody OTC Stock
Goodbody Health financial ratios help investors to determine whether Goodbody OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Goodbody with respect to the benefits of owning Goodbody Health security.